{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:05:13Z","timestamp":1794254713591,"version":"4.9.0"},"reference-count":40,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T00:00:00Z","timestamp":1670112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The anti-M\u00fcllerian hormone (AMH) plays an essential role in sex determination in early embryonic development. Through a series of sequential steps that follows inheriting an XY chromosome, Sertoli cell differentiation upregulates the expression of AMH-suppressing M\u00fcllerian duct development and maintains the AMH at a high level until puberty. In females, the AMH is produced by granulosa cells of follicles beginning in the second half of fetal life and continues through adulthood, with a steady decline through the reproductive years and severe decline at menopause, until levels eventually become undetectable. The AMH is essential for the regulation of follicular maturation via the recruitment of primordial follicles throughout folliculogenesis. AMH serum concentration in women strongly correlates with ovarian reserve quantity and reflects ovulation potential. Because the AMH is expressed almost exclusively by growing follicles before FSH-dependent selection, it commonly serves as a marker for ovarian function in various clinical situations, including in the diagnosis and pathogenesis of polycystic ovarian syndrome, artificial reproductive technology, and predictions of menopause or premature ovarian failure.<\/jats:p>","DOI":"10.3390\/jcm11237209","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T06:29:09Z","timestamp":1670221749000},"page":"7209","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical Utilities of Anti-M\u00fcllerian Hormone"],"prefix":"10.3390","volume":"11","author":[{"given":"Nicole","family":"Russell","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, University of South Carolina School of Medicine Greenville, Greenville, SC 29605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gilmore","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of South Carolina School of Medicine Greenville, Greenville, SC 29605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Roudebush","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of South Carolina School of Medicine Greenville, Greenville, SC 29605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,4]]},"reference":[{"key":"ref_1","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Hershman, J.M., Hofland, J., and Kalra, S. (2000). Sexual Differentiation, MDText.com, Inc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13224-020-01362-0","article-title":"AMH and Its Clinical Implications","volume":"70","author":"Shrikhande","year":"2020","journal-title":"J. Obstet. Gynecol. India"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Kunicki, M., Calik-Ksepka, A., Suchta, K., Duszewska, A., Smolarczyk, K., and Smolarczyk, R. (2021). Anti-M\u00fcllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212507"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yue, C.Y., Lu, L.K., Li, M., Zhang, Q.L., and Ying, C.M. (2018). Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203129"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7827-11-60","article-title":"Anti-Mullerian-hormone levels during pregnancy and postpartum","volume":"11","author":"Kauth","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1210\/jc.2012-1213","article-title":"The level of serum anti-M\u00fcllerian hormone correlates with vitamin D status in men and women but not in boys","volume":"97","author":"Dennis","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","first-page":"17","article-title":"Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH","volume":"18","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril., 81, 19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.fertnstert.2005.10.057","article-title":"Serum anti-m\u00fcllerian hormone levels in women with secondary amenorrhea","volume":"85","author":"Pati","year":"2006","journal-title":"Fertil. Steril."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wiweko, B., Indra, I., Susanto, C., Natadisastra, M., and Hestiantoro, A. (2018). The correlation between serum AMH and HOMA-IR among PCOS phenotypes. BMC Res. Notes, 11.","DOI":"10.1186\/s13104-018-3207-y"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e10390","DOI":"10.7717\/peerj.10390","article-title":"The relationship between anti-M\u00fcllerian hormone (AMH) levels and pregnancy outcomes in patients undergoing assisted reproductive techniques (ART)","volume":"8","author":"Umarsingh","year":"2020","journal-title":"PeerJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10815-015-0571-6","article-title":"Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: A retrospective cohort study","volume":"32","author":"Chen","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","article-title":"The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility","volume":"37","author":"Bedenk","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_17","first-page":"387\u2013396.e4","article-title":"ESTHER-1 study group. Individualized versus conventional ovarian stimulation for in vitro fertilization: A multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nelson","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_18","first-page":"24","article-title":"Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF?","volume":"10","author":"Goswami","year":"2017","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.fertnstert.2015.06.007","article-title":"Antim\u00fcllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng\/mL versus 1\u20134 ng\/mL","volume":"104","author":"Kavoussi","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Coccia, M.E., Nardone, L., and Rizzello, F. (2022). Endometriosis and Infertility: A Long-Life Approach to Preserve Reproductive Integrity. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19106162"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Henry, L., Vervier, J., Boucher, A., Brichant, G., Gaspard, O., Labied, S., Munaut, C., Ravet, S., and Nisolle, M. (2022). Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154559"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"600202","DOI":"10.3389\/fsurg.2020.600202","article-title":"AMH Concentrations in Peritoneal Fluids of Women with and without Endometriosis","volume":"7","author":"Kitajima","year":"2020","journal-title":"Front. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13287-017-0745-5","article-title":"Effects of hPMSCs on granulosa cell apoptosis and AMH expression and their role in the restoration of ovary function in premature ovarian failure mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"794117","DOI":"10.3389\/fendo.2021.794117","article-title":"The Significance of Planned Fertility Preservation for Women with Endometrioma Before an Expected Ovarian Cystectomy","volume":"12","author":"Hong","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_25","first-page":"51","article-title":"Premature ovarian failure","volume":"16","author":"Jankowska","year":"2017","journal-title":"Prz. Menopauzalny"},{"key":"ref_26","first-page":"105","article-title":"Premature ovarian insufficiency\u2014Aetiopathology, epidemiology, and diagnostic evaluation","volume":"17","author":"Rudnicka","year":"2018","journal-title":"Prz. Menopauzalny"},{"key":"ref_27","first-page":"629","article-title":"Genetic Etiology of Primary Premature Ovarian Insufficiency","volume":"55","author":"Marina","year":"2016","journal-title":"Acta Clin. Croat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ogc.2012.09.007","article-title":"A new approach to primary ovarian insufficiency","volume":"39","author":"Rafique","year":"2012","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e21753","DOI":"10.1096\/fj.202100756R","article-title":"A kaleidoscopic view of ovarian genes associated with premature ovarian insufficiency and senescence","volume":"35","author":"Yang","year":"2021","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5603\/GP.a2021.0111","article-title":"Fresh insight into premature ovarian insufficiency","volume":"92","author":"Karska","year":"2021","journal-title":"Ginekol. Pol."},{"key":"ref_31","first-page":"47","article-title":"Anti-Mullerian (AMH) as a good predictor of time of menopause","volume":"16","year":"2017","journal-title":"Menopause Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0035-1567825","article-title":"Genetics of Early and Normal Menopause","volume":"33","author":"Laven","year":"2015","journal-title":"Semin. Reprod. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/humrep\/det446","article-title":"Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother\u2019s age at menopause","volume":"29","author":"Depmann","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.mcna.2015.01.006","article-title":"Menopause","volume":"99","author":"Takahashi","year":"2015","journal-title":"Med. Clin. North Am."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/gme.0b013e318205e2ac","article-title":"Predicting age at menopause from serum antim\u00fcllerian hormone concentration","volume":"18","author":"Tehrani","year":"2011","journal-title":"Menopause"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1210\/jc.2010-0701","article-title":"Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology","volume":"95","author":"Ledger","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: Ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10815-019-01507-9","article-title":"Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects","volume":"36","author":"Roness","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"733731","DOI":"10.3389\/fendo.2021.733731","article-title":"Role of AMH in Prediction of Menopause","volume":"12","author":"Broekmans","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1210\/jc.2018-00724","article-title":"Does AMH relate to timing of menopause? Results of an Individual Patient Data meta-analysis","volume":"103","author":"Depmann","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/23\/7209\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:33:53Z","timestamp":1760146433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/23\/7209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,4]]},"references-count":40,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["jcm11237209"],"URL":"https:\/\/doi.org\/10.3390\/jcm11237209","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,4]]}}}